Company / Income Tax
Arrowhead Pharmaceuticals Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$21.4M
FY2025
5-year range
-$2.8M / $21.4M
FY2021-FY2025
Trend
+874.1%
vs FY2024
Sector context
#39 of 204
Health Care
What the data says
Income Tax changed +874% YoY in FY2025, a notable deviation from the 9-year average annual change of -15288%.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +539.7%. Top quartile in the Health Care sector.
Increased from $2,000 to $21M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +539.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 204This company $21.4M Sector average $118.7M
▼
-82.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +539.7%, indicating consistent growth.
- In FY2025, income tax increased 874.1% year-over-year.
- Ranks #39 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.4M | +874.1% |
| FY2024 | -$2.8M | -138450.0% |
| FY2023 | $2.0K | +0.0% |
| FY2022 | $2.0K | +0.0% |
| FY2021 | $2.0K | +0.0% |
| FY2020 | $2.0K | -16.7% |
| FY2019 | $2.4K | +0.0% |
| FY2018 | $2.4K | +0.0% |
| FY2017 | $2.4K | +0.0% |
| FY2016 | $2.4K | -54.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026